Molnupiravir is considered a potential antiviral treatment for COVID-19. This newly developed drug acts to inhibit the replication of the SARS-CoV-2 virus, seeking to lessen the severity of illness. Clinical trials https://www.milanmedicals.com/molnupiravir-200-mg